Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Haleon PLC ( (GB:HLN) ) has shared an announcement.
Haleon PLC announced that as of July 31, 2025, the total number of shares issued is 8,987,651,560, with 3,880,205 held as treasury shares. This results in 8,983,771,355 ordinary shares with voting rights, a crucial figure for shareholders and others with notification obligations under the FCA’s Disclosure Guidance and Transparency Rules. This update is significant for stakeholders as it impacts the calculation of notifiable interests in the company.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £3.70 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Spark’s Take on GB:HLN Stock
According to Spark, TipRanks’ AI Analyst, GB:HLN is a Neutral.
Haleon PLC’s overall stock score is driven by strong financial performance and positive earnings call outlook, supported by strategic growth initiatives and innovation. However, technical analysis and valuation indicate some caution, with bearish trends and moderate income returns. The company’s resilience in challenging markets and commitment to shareholder returns through buybacks and dividends bolster confidence.
To see Spark’s full report on GB:HLN stock, click here.
More about Haleon PLC
Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with a human touch. The company offers a diverse range of products across six major categories, including Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Its portfolio includes well-known brands such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren.
Average Trading Volume: 23,484,107
Technical Sentiment Signal: Hold
Current Market Cap: £32.3B
Learn more about HLN stock on TipRanks’ Stock Analysis page.